Renovis News (NASDAQ:RNVS)
| Latest Renovis News Headlines | | Date | Time | Source | | | 05/01/2008 | 11:55AM | PRNUS | Renovis Stockholders Approve Acquisition by Evotec
SOUTH SAN FRANCISCO, Calif., May 1 /PRNewswire-FirstCall/ -- Renovis, Inc. (NASDAQ:RNVS) announced today that its stockholders approved the adoption of the merger agreement with Evotec AG (Frankfurt Stock Exchange: EVT) at a special meeting of stockholders held today. The merger is expected to close by May 5, 2008.
In... More...>> |
| 04/25/2008 | 2:30PM | PRNUS | Proxy Governance and Egan-Jones Recommend Renovis Shareholders Vote For Merger With Evotec
SOUTH SAN FRANCISCO, Calif., April 25 /PRNewswire-FirstCall/ -- Renovis, Inc. (NASDAQ:RNVS), today announced that PROXY Governance, Inc. and Egan-Jones Proxy Services have joined ISS/Risk Metrics and Glass Lewis & Co. in recommending that Renovis stockholders vote "FOR" the merger agreement with Evotec AG (Frankfurt... More...>> |
| 04/22/2008 | 8:30AM | PRNUS | Glass Lewis & Co. Recommends Renovis Shareholders Vote For Merger With Evotec
SOUTH SAN FRANCISCO, April 22 /PRNewswire-FirstCall/ -- Renovis, Inc. (NASDAQ:RNVS), today announced that Glass Lewis & Co., a leading proxy advisory firm, has joined ISS/Risk Metrics in recommending that Renovis stockholders vote "FOR" the merger agreement with Evotec AG (Frankfurt Stock Exchange: EVT) at the Special... More...>> |
| 04/18/2008 | 3:30PM | PRNUS | ISS/Risk Metrics Recommends Renovis Shareholders Vote for Merger With Evotec
SOUTH SAN FRANCISCO, Calif., April 18 /PRNewswire-FirstCall/ -- Renovis, Inc. (NASDAQ:RNVS), today announced that Institutional Shareholder Services (ISS), one of the nation's leading proxy advisory firms, has recommended that Renovis stockholders vote "FOR" the merger agreement with Evotec AG (Frankfurt Stock Exchange:... More...>> |
| 04/03/2008 | 4:05PM | PRNUS | Renovis Announces Expiration of Hart-Scott-Rodino (HSR) 30-Day Waiting Period; Merger With Evotec on Track to Close in Early May
SOUTH SAN FRANCISCO, Calif., April 3, 2008 /PRNewswire-FirstCall/ -- Renovis, Inc. (NASDAQ:RNVS), a biopharmaceutical company focused on the discovery and development of drugs for major medical needs in the areas of neurological and inflammatory diseases, announced today that the waiting period under the Hart-Scott-Rodino... More...>> |
| 03/14/2008 | 4:30PM | PRNUS | Renovis Reports Fourth Quarter and Full Year 2007 Financial Results
SOUTH SAN FRANCISCO, Calif., March 14 /PRNewswire-FirstCall/ -- Renovis, Inc. (NASDAQ:RNVS), a biopharmaceutical company focused on the discovery and development of drugs for major medical needs in the areas of neurological and inflammatory diseases, today announced financial results for the fourth quarter and year... More...>> |
| 11/06/2007 | 5:00PM | PRNUS | Renovis Reports Third Quarter 2007 Financial Results
SOUTH SAN FRANCISCO, Calif., Nov. 6 /PRNewswire-FirstCall/ -- Renovis, Inc. (NASDAQ:RNVS), a biopharmaceutical company focused on the discovery and development of drugs for major medical needs in the areas of neurological and inflammatory diseases, today announced financial results for the third quarter ended September... More...>> |
| 11/01/2007 | 5:00PM | PRNUS | Renovis to Present at CIBC World Markets Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Nov. 1 /PRNewswire-FirstCall/ -- Renovis, Inc. (NASDAQ:RNVS) announced today Executive Chairman John Walker will present an overview of the company at the CIBC 18th Annual Healthcare Conference in New York, New York on Wednesday, November 7, 2007 at 11:30 a.m. Eastern Standard Time (8:30... More...>> |
| 10/01/2007 | 7:00PM | PRNUS | Renovis Announces Management Changes
CEO Corey Goodman Steps Down; John Walker, Board Chair, Named Executive Chairman
SOUTH SAN FRANCISCO, Calif., Oct. 1 /PRNewswire-FirstCall/ -- Renovis, Inc. (NASDAQ:RNVS), a biopharmaceutical company focused on the discovery and development of drugs for major medical needs in the areas of neurological and inflammatory... More...>> |
| 08/07/2007 | 4:30PM | PRNUS | Renovis Reports Second Quarter 2007 Financial Results
SOUTH SAN FRANCISCO, Calif., Aug. 7 /PRNewswire-FirstCall/ -- Renovis, Inc. (NASDAQ:RNVS), a biopharmaceutical company focused on the discovery and development of drugs for major medical needs in the areas of neurological and inflammatory diseases, today announced financial results for the second quarter ended June... More...>> |
| 06/28/2007 | 9:00AM | PRNUS | Renovis Announces Management Changes
SOUTH SAN FRANCISCO, Calif., June 28 /PRNewswire-FirstCall/ -- Renovis, Inc. (NASDAQ:RNVS), a biopharmaceutical company focused on the discovery and development of drugs for major medical needs in the areas of neurological and inflammatory diseases, today announced the promotions of three key employees to management... More...>> |
| 06/08/2007 | 9:00AM | PRNUS | Renovis Announces Achievement of Milestones in VR1 Collaboration with Pfizer Inc.
SOUTH SAN FRANCISCO, June 8 /PRNewswire-FirstCall/ -- Renovis, Inc. (NASDAQ:RNVS), a biopharmaceutical company focused on the discovery and development of drugs for major medical needs in the areas of neurological and inflammatory diseases, today announced the achievement of two milestones in its research collaboration... More...>> |
| 05/08/2007 | 4:30PM | PRNUS | Renovis Reports First Quarter 2007 Financial Results
SOUTH SAN FRANCISCO, Calif., May 8 /PRNewswire-FirstCall/ -- Renovis, Inc. (NASDAQ:RNVS), a biopharmaceutical company focused on the discovery and development of drugs for major medical needs in the areas of neurological and inflammatory diseases, today announced financial results for the first quarter ended March 31... More...>> |
| 04/10/2007 | 8:30AM | PRNUS | Pfizer and Renovis Extend Research Collaboration to Identify Small Molecule VR1 Antagonists
SOUTH SAN FRANCISCO, Calif., April 10 /PRNewswire-FirstCall/ -- Renovis, Inc. (NASDAQ:RNVS), a biopharmaceutical company focused on the discovery and development of drugs for major medical needs in the areas of neurological and inflammatory diseases, today announced an agreement with Pfizer Inc. (NYSE:PFE) to extend... More...>> |
| 04/09/2007 | 8:30AM | PRNUS | Renovis to Present at the CIBC Biotechnology and Specialty Pharmaceuticals Conference
SOUTH SAN FRANCISCO, Calif., April 9 /PRNewswire-FirstCall/ -- Renovis, Inc. (NASDAQ:RNVS) today announced that Corey S. Goodman, Ph.D., President and Chief Executive Officer, will present at the CIBC Biotechnology and Specialty Pharmaceuticals Conference in New York on Thursday, April 12 at 8:00 a.m. Eastern Daylight... More...>> |
| 03/08/2007 | 8:00AM | PRNUS | Renovis to Present at the Cowen & Co. 27th Annual Health Care Conference
SOUTH SAN FRANCISCO, Calif., March 8 /PRNewswire-FirstCall/ -- Renovis, Inc. (NASDAQ:RNVS) today announced that Corey S. Goodman, Ph.D., President and Chief Executive Officer, will present at the Cowen & Co. 27th Annual Health Care Conference in Boston, Massachusetts on Tuesday, March 13 at 11:00 a.m. Eastern Daylight... More...>> |
| 03/01/2007 | 4:54PM | PRNUS | Renovis Reports Fourth Quarter and Full Year 2006 Financial Results
SOUTH SAN FRANCISCO, Calif., March 1 /PRNewswire-FirstCall/ -- Renovis, Inc. (NASDAQ:RNVS), a biopharmaceutical company focused on the discovery and development of drugs for major medical needs in the areas of neurological and inflammatory diseases, today announced financial results for the fourth quarter and year ended... More...>> |
| 02/09/2007 | 8:00AM | PRNUS | Renovis to Present at the 9th Annual BIO CEO conference
SOUTH SAN FRANCISCO, Calif., Feb. 9 /PRNewswire-FirstCall/ -- Renovis, Inc. (NASDAQ:RNVS) today announced that Corey S. Goodman, Ph.D., President and Chief Executive Officer, will present at the 9th Annual BIO CEO Conference in New York, NY on Tuesday, February 13 at 1:30 p.m. Eastern Time. The presentation will be... More...>> |
| 01/23/2007 | 5:00PM | PRNUS | Renovis Restructures to Focus on Advancing Its Neurological and Inflammatory Disease Programs Into Clinical Trials
SOUTH SAN FRANCISCO, Calif., Jan. 23 /PRNewswire-FirstCall/ -- Renovis, Inc. (NASDAQ:RNVS) today announced that it has reduced its workforce by approximately 40 percent of its positions as part of a restructuring plan intended to significantly reduce spending while maintaining the research and development capabilities... More...>> |
| 01/03/2007 | 9:01AM | PRNUS | Renovis Announces Management Changes
SOUTH SAN FRANCISCO, Calif., Jan. 3 /PRNewswire-FirstCall/ -- Renovis, Inc. (NASDAQ:RNVS), today announced changes in the Company's management team. Donald R. Joseph, Senior Vice President, Corporate Development and General Counsel, is leaving the Company to take a senior operations position with a private entity in... More...>> |
|
|
|